Shasha Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shasha Chen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Zhongjun Dong
The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei, China
21 shared publications - Junming He
Beijing Tsinghua Changgung Hospital School of Clinical Medicine Tsinghua University Beijing 102218 China
19 shared publications - Meixiang Yang
Guangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People’s Hospital), Jinan University, Heyuan, China
19 shared publications - Yuande Wang
State Key Laboratory of Gene Expression, School of Medicine, School of Life Science, Westlake University , Hangzhou, Zhejiang 310024
19 shared publications - Donglin Chen
State Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, China
18 shared publications - Wei Xiong
State Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing, China
18 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
METTL14-mediated m6A methylation orchestrates early NK cell development by maintaining metabolic fitness
N6-methyladenosine (m 6 A) represents the most abundant mRNA modification, yet its role in natural killer (NK) cell development remains incompletely understood. Here we demonstrate that the m 6 A methyltransferase METTL14 plays an indispensable, stage-specific role in early NK cell development. Mettl14 deficiency at the progenitor stage caused severe NK cell lymphopenia by disrupting the NK progenitor to immature NK cell transition. Paradoxically, residual Mettl14 -null NK cells exhibited a hypermetabolic state characterized by mTORC1 hyperactivation and enhanced mitochondrial function, which drove both hyperproliferation and activation-induced cell death via p53 and apoptotic pathway activation. Despite developmental defects, these cells demonstrated superior capacity to control melanoma metastasis in vivo. Mechanistically, METTL14 fine-tuned IL-15 responsiveness likely by sustaining SOCS3 expression to restrain JAK-STAT5 signaling. Terminal deletion of Mettl14 produced no phenotype, underscoring its specific requirement during early development. Our findings establish METTL14 as a crucial checkpoint coordinating transcriptional and metabolic programs to ensure NK cell homeostasis.
- 28 July 2026
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessMETTL14-mediated m6A methylation orchestrates early NK cell development by maintaining metabolic fitness
N6-methyladenosine (m 6 A) represents the most abundant mRNA modification, yet its role in natural killer (NK) cell development remains incompletely understood. Here we demonstrate that the m 6 A methyltransferase METTL14 plays an indispensable, stage-specific role in early NK cell development. Mettl14 deficiency at the progenitor stage caused severe NK cell lymphopenia by disrupting the NK progenitor to immature NK cell transition. Paradoxically, residual Mettl14 -null NK cells exhibited a hypermetabolic state characterized by mTORC1 hyperactivation and enhanced mitochondrial function, which drove both hyperproliferation and activation-induced cell death via p53 and apoptotic pathway activation. Despite developmental defects, these cells demonstrated superior capacity to control melanoma metastasis in vivo. Mechanistically, METTL14 fine-tuned IL-15 responsiveness likely by sustaining SOCS3 expression to restrain JAK-STAT5 signaling. Terminal deletion of Mettl14 produced no phenotype, underscoring its specific requirement during early development. Our findings establish METTL14 as a crucial checkpoint coordinating transcriptional and metabolic programs to ensure NK cell homeostasis.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR-fed mice maintained their ability to suppress the growth of lung melanoma tumor cells, despite CD8 T cell depletion.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR-fed mice maintained their ability to suppress the growth of lung melanoma tumor cells, despite CD8 T cell depletion.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Gene Ontology (GO) enrichment analysis on differential marker expression patterns in clusters of NK cells under dietary restriction (DR) compared to control.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Gene Ontology (GO) enrichment analysis on differential marker expression patterns in clusters of NK cells under dietary restriction (DR) compared to control.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Trajectory analysis NK cell development from normal diet or DR-fed mice.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Trajectory analysis NK cell development from normal diet or DR-fed mice.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
The less accessible loci found in cluster 3.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
The less accessible loci found in cluster 3.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR-fed mice promote the accumulation of DP NK cells by enhancing the expression of Eomes and its downstream target CXCR3.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR-fed mice promote the accumulation of DP NK cells by enhancing the expression of Eomes and its downstream target CXCR3.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Single-cell RNA sequencing analysis the expression of CD27 and CD11b in NK cell clusters from DR-fed mice.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Single-cell RNA sequencing analysis the expression of CD27 and CD11b in NK cell clusters from DR-fed mice.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR treatment enriches the Eomes expression and functional DP NK cells by suppressing mTORC1 signaling.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
DR treatment enriches the Eomes expression and functional DP NK cells by suppressing mTORC1 signaling.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
T-bet deficiency does not impact NK cell activation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
T-bet deficiency does not impact NK cell activation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Abnormal metabolism in tumor cells represents a potential target for tumor therapy. In this regard, dietary restriction (DR) or its combination with anticancer drugs is of interest as it can impede the growth of tumor cells. In addition to its effects on tumor cells, DR also plays an extrinsic role in restricting tumor growth by regulating immune cells. NK cells are innate immune cells involved in tumor immunosurveillance. However, it remains uncertain whether DR can assist NK cells in controlling tumor growth. In this study, we demonstrate that DR effectively inhibits metastasis of melanoma cells to the lung. Consistent with this, the regression of tumors induced by DR was minimal in mice lacking NK cells. Single-cell RNA sequencing analysis revealed that DR enriched a rejuvenated subset of CD27+CD11b+ NK cells. Mechanistically, DR activated a regulatory network involving the transcription factor Eomesodermin (Eomes), which is essential for NK-cell development. First, DR promoted the expression of Eomes by optimizing mTORC1 signaling. The upregulation of Eomes revived the subset of functional CD27+CD11b+ NK cells by counteracting the expression of T-bet and downstream Zeb2. Moreover, DR enhanced the function and chemotaxis of NK cells by increasing the accessibility of Eomes to chromatin, leading to elevated expression of adhesion molecules and chemokines. Consequently, we conclude that DR therapy enhances tumor immunity through nontumor autonomous mechanisms, including promoting NK-cell tumor immunosurveillance and activation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from A Single-Cell Analysis of the NK-Cell Landscape Reveals That Dietary Restriction Boosts NK-Cell Antitumor Immunity via Eomesodermin
Abnormal metabolism in tumor cells represents a potential target for tumor therapy. In this regard, dietary restriction (DR) or its combination with anticancer drugs is of interest as it can impede the growth of tumor cells. In addition to its effects on tumor cells, DR also plays an extrinsic role in restricting tumor growth by regulating immune cells. NK cells are innate immune cells involved in tumor immunosurveillance. However, it remains uncertain whether DR can assist NK cells in controlling tumor growth. In this study, we demonstrate that DR effectively inhibits metastasis of melanoma cells to the lung. Consistent with this, the regression of tumors induced by DR was minimal in mice lacking NK cells. Single-cell RNA sequencing analysis revealed that DR enriched a rejuvenated subset of CD27+CD11b+ NK cells. Mechanistically, DR activated a regulatory network involving the transcription factor Eomesodermin (Eomes), which is essential for NK-cell development. First, DR promoted the expression of Eomes by optimizing mTORC1 signaling. The upregulation of Eomes revived the subset of functional CD27+CD11b+ NK cells by counteracting the expression of T-bet and downstream Zeb2. Moreover, DR enhanced the function and chemotaxis of NK cells by increasing the accessibility of Eomes to chromatin, leading to elevated expression of adhesion molecules and chemokines. Consequently, we conclude that DR therapy enhances tumor immunity through nontumor autonomous mechanisms, including promoting NK-cell tumor immunosurveillance and activation.